Literature DB >> 11095790

Septic Shock and Toxic Shock: Do Adjunctive Therapies Improve Outcome?

.   

Abstract

Entities:  

Year:  1999        PMID： 11095790     DOI： 10.1007/s11908-999-0021-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  10 in total

1.  Anti-endotoxin monoclonal antibodies.

Authors:  H S Warren; R L Danner; R S Munford
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

2.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

3.  Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.

Authors:  B Derkx; J Wittes; R McCloskey
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

Review 4.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 5.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

Review 6.  Septic shock.

Authors:  M E Astiz; E C Rackow
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

Review 7.  Streptococcal infections of skin and soft tissues.

Authors:  A L Bisno; D L Stevens
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

8.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

9.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

10.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245
  10 in total
  1 in total

1.  Characterization of the interaction of staphylococcal enterotoxin B with CD1d expressed in human renal proximal tubule epithelial cells.

Authors:  Rasha Hammamieh; Nabarun Chakraborty; Yixin Lin; Jeffrey W Shupp; Stacy-Ann Miller; Sam Morris; Marti Jett
Journal:  BMC Microbiol       Date:  2015-02-04       Impact factor: 3.605
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.